NVNO Market Analysis

Overview

Fundamentals

P/E ratio
EPS (TTM)$-33.060.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$6.9MMicro cap

Valuation

Forward P/E
PEG ratio
P/B
0.25
P/S (TTM)
216.91
EV/EBITDA
-0.87

Profitability & growth

ROE (TTM)
-56.2%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
Beta
1.08
Last earnings
May 4, 2026 · Estimate $-0.24 · Reported $0.00
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About enVVeno Medical Corp

enVVeno Medical Corp is an innovative medical device company dedicated to transforming vascular access solutions for dialysis patients through its proprietary biocompatible technology. By addressing critical unmet needs in the dialysis sector, enVVeno enhances the safety and efficacy of vascular procedures, allowing it to capitalize on the growing vascular interventions market. The company's commitment to advanced engineering, coupled with stringent regulatory compliance, aligns it with the evolving healthcare landscape and reinforces its mission to improve patient outcomes in a vital area of…

Classification

Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
70 DOPPLER, IRVINE, CA
Fiscal year end
December
Latest quarter
Dec 31, 2025
Market cap$6.9M
Shares outstanding$655520
52W high$196.70
52W low$8.67

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer